Grifols

Barcelona, Spain (U.S. operations: Research Triangle Park, NC)

Grifols is a global healthcare company and one of the largest producers of plasma-derived medicines. Their immunoglobulin products are used to treat primary immunodeficiency, CIDP, and other conditions requiring immunoglobulin replacement or immunomodulation.

Drugs

Hub Program — Grifols MyIgSource

  • Insurance and benefits verification
  • Prior authorization assistance
  • Copay support for commercially insured patients
  • Patient assistance for eligible uninsured patients
  • Nursing support for home infusion patients

Patient Assistance

Copay Assistance

Grifols offers copay assistance for eligible commercially insured patients receiving Gamunex-C, Gammaked, Gammaplex, or Xembify.

Patient Assistance Program (PAP)

Grifols Patient Assistance Program provides medication at no cost to eligible patients without adequate insurance coverage.

Denied a Grifols Drug?

Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.